Crypto ETFs saw outflows of about $593 million in the week through October 16, marking a 52% decline from the previous week's $1.2 billion but still reflecting ongoing selling pressure. Bitcoin ETFs lost roughly $229 million, while Ether ETFs faced heavier pressure with $320 million withdrawn, representing over 2% of their assets under management. Solana ETFs also experienced significant outflows, continuing a 10-day streak of withdrawals. NEAR was an exception, attracting $11.65 million in inflows as investors remained selective amid inflation concerns and a cautious macroeconomic environment. The slowdown in outflows suggests some stabilization, but institutional investors remain defensive amid inflation-driven rate uncertainties.
Crypto ETFs experienced outflows of about $593 million in the week through October 16, indicating ongoing selling pressure. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 19, 2026 21:22 WIB: out of 50 priced major cryptocurrencies, 40 rose and 9 fell today. Notable movers include SXP (Solar) down 46.27% at Rp37 with a typical hold time of 94 days, BAL (Balancer) up 11.14% at Rp16.297 with a hold time of 85 days, and EOS (EOS.IO) up 8.13% at Rp12.649 with a hold time of 87 days.
Bill Gross, a serial entrepreneur behind over 175 companies, has launched Idealab.ai, a platform using AI to generate and share over 1.2 million business ideas based on real-world problems. The platform aims to lower barriers to entrepreneurship by h...
The Portnoy Law Firm has launched an investigation into Cardinal Infrastructure Group for possible securities fraud following the company's Q2 2026 financial report. Cardinal revealed a decline in its gross profit margin to 10.8%, down from 13.9% the...
AIOS Tech Inc. announced an agreement to acquire SmartCore Holdings Limited in an all-stock transaction valued at approximately $100 million. The deal will issue 33.3 million AIOS shares to SmartCore's sellers, who will hold about 80% of AIOS shares ...
XBiotech announced positive results from the Phase II TASKIN trial, where their antibody vilamakitug combined with standard chemotherapy improved 12-month overall survival to 61.3% in refractory metastatic colorectal cancer patients, surpassing the s...
Proof and Circle Internet Group demonstrated a new system where AI agents can prove the identity of the person they represent using Proof's x401 open identity protocol and pay merchants in USDC via Circle's x402 payment protocol. This innovation addr...
